Trials / Completed
CompletedNCT00235859
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Human Anti-TNF Antibody Adalimumab Administered as Subcutaneous Injections in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the safety and efficacy of adalimumab compared to placebo in subjects with rheumatoid arthritis on methotrexate therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adalimumab | |
| DRUG | methotrexate |
Timeline
- Start date
- 2003-07-01
- First posted
- 2005-10-12
- Last updated
- 2007-08-29
Source: ClinicalTrials.gov record NCT00235859. Inclusion in this directory is not an endorsement.